Diversity of astroglial responses across human neurodegenerative disorders and brain aging |
| |
| Authors: | Isidro Ferrer |
| |
| Affiliation: | 1. Department of Pathology and Experimental Therapeutics, University of Barcelona, Barcelona, Spain;2. Institute of Neuropathology, Pathologic Anatomy Service, Bellvitge University Hospital, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain;3. Institute of Neurosciences, University of Barcelona, Barcelona, Spain;4. Biomedical Network Research Center on Neurodegenerative Diseases (CIBERNED), Institute Carlos III, Madrid, Spain |
| |
| Abstract: | Astrogliopathy refers to alterations of astrocytes occurring in diseases of the nervous system, and it implies the involvement of astrocytes as key elements in the pathogenesis and pathology of diseases and injuries of the central nervous system. Reactive astrocytosis refers to the response of astrocytes to different insults to the nervous system, whereas astrocytopathy indicates hypertrophy, atrophy/degeneration and loss of function and pathological remodeling occurring as a primary cause of a disease or as a factor contributing to the development and progression of a particular disease. Reactive astrocytosis secondary to neuron loss and astrocytopathy due to intrinsic alterations of astrocytes occur in neurodegenerative diseases, overlap each other, and, together with astrocyte senescence, contribute to disease‐specific astrogliopathy in aging and neurodegenerative diseases with abnormal protein aggregates in old age. In addition to the well‐known increase in glial fibrillary acidic protein and other proteins in reactive astrocytes, astrocytopathy is evidenced by deposition of abnormal proteins such as β‐amyloid, hyper‐phosphorylated tau, abnormal α‐synuclein, mutated huntingtin, phosphorylated TDP‐43 and mutated SOD1, and PrPres, in Alzheimer's disease, tauopathies, Lewy body diseases, Huntington's disease, amyotrophic lateral sclerosis and Creutzfeldt‐Jakob disease, respectively. Astrocytopathy in these diseases can also be manifested by impaired glutamate transport; abnormal metabolism and release of neurotransmitters; altered potassium, calcium and water channels resulting in abnormal ion and water homeostasis; abnormal glucose metabolism; abnormal lipid and, particularly, cholesterol metabolism; increased oxidative damage and altered oxidative stress responses; increased production of cytokines and mediators of the inflammatory response; altered expression of connexins with deterioration of cell‐to‐cell networks and transfer of gliotransmitters; and worsening function of the blood brain barrier, among others. Increased knowledge of these aspects will permit a better understanding of brain aging and neurodegenerative diseases in old age as complex disorders in which neurons are not the only players. |
| |
| Keywords: | aging astrocytes astrocytic gliosis astrocytopathy astrogliopathy neurodegenerative diseases with abnormal protein aggregates |
|
|
